Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with BOLT: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
BOLT
Bolt Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
BOLT
Bolt Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No disclosed counterparties: BOLT.
Only BOLT
0
None
Role chip = supplier or customer
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,342.37
· delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
BOLT
Bolt Biotherapeutics, Inc.
Change
6.18
· pre 6.50
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$12.3M
Revenue
$5,000
Q2 FY26
Revenue
$8M
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
LLY
ELI Lilly & Co
vs
BOLT
Bolt Biotherapeutics, Inc.
1,371.32
pre 1,342.37
delayed
Price
6.18
pre 6.50
delayed
$1.2T
Mkt cap
$12.3M
Q3 FY26
$24.4B
Revenue
$5,000
Q2 FY26
FY25
$65.2B
Revenue
$8M
FY25
Change
Change
LLY
1,371.32
vs
BOLT
6.18
Pre-market
Nov 6 '26
delayed